Your browser doesn't support javascript.
loading
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law, John L M; Logan, Michael; Wong, Jason; Kundu, Juthika; Hockman, Darren; Landi, Amir; Chen, Chao; Crawford, Kevin; Wininger, Mark; Johnson, Janelle; Mesa Prince, Catalina; Dudek, Elzbieta; Mehta, Ninad; Tyrrell, D Lorne; Houghton, Michael.
Afiliación
  • Law JLM; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada llaw@ualberta.ca michael.houghton@ualberta.ca.
  • Logan M; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Wong J; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Kundu J; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Hockman D; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Landi A; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Chen C; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Crawford K; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Wininger M; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Johnson J; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Mesa Prince C; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Dudek E; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Mehta N; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Tyrrell DL; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Houghton M; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada llaw@ualberta.ca michael.houghton@ualberta.ca.
J Virol ; 92(11)2018 06 01.
Article en En | MEDLINE | ID: mdl-29540595
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Virales / Vacunas contra Hepatitis Viral / Proteínas del Envoltorio Viral / Hepatitis C / Hepacivirus / Antígenos de la Hepatitis C Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Virol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Virales / Vacunas contra Hepatitis Viral / Proteínas del Envoltorio Viral / Hepatitis C / Hepacivirus / Antígenos de la Hepatitis C Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Virol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos